Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VECAM 40/300 vs Esomeprazole in GERD
NCT01059383Phase 2Completed
- Start
- Dec 2009
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of omeprazole + succinic acid in gastroesophageal reflux disease (GERD). Started Dec 2009; status: completed.
02
Drugs
omeprazole + succinic acid
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT01059383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01059383.